Form 4: Neumora Therapeutics Executive Sells Shares

Sentiment:

Insider Transaction (Form 4)


Daljit Singh Aurora, See Remarks of Neumora Therapeutics, Inc., sold 176,060 shares of common stock on August 20, 2026.

Summary

  • Option exercise/conversion: acquired 67,741 Common Stock at $0.72 ($48,774) on August 20, 2026; holds 116,491 after (Direct).
  • Open-market sale: disposed of 67,741 Common Stock at $1.51 ($102,587) on August 20, 2026; holds 48,750 after (Direct).
  • Option exercise/conversion: acquired 21,685 Common Stock at $0.72 ($15,613) on August 20, 2026; holds 21,685 after (Indirect).
  • Option exercise/conversion: acquired 45,026 Common Stock at $0.72 ($32,419) on August 20, 2026; holds 66,711 after (Indirect).
  • Open-market sale: disposed of 66,711 Common Stock at $1.51 ($101,000) on August 20, 2026 (Indirect).
  • Option exercise/conversion: acquired 20,553 Common Stock at $0.72 ($14,798) on August 21, 2026; holds 69,303 after (Direct).
  • Open-market sale: disposed of 20,553 Common Stock at $1.59 ($32,780) on August 21, 2026; holds 48,750 after (Direct).
  • Option exercise/conversion: acquired 21,055 Common Stock at $0.72 ($15,160) on August 21, 2026; holds 21,055 after (Indirect).
  • Open-market sale: disposed of 21,055 Common Stock at $1.60 ($33,600) on August 21, 2026 (Indirect).
  • Option exercise/conversion: disposed of 67,741 Stock Option (Right to Buy) on August 20, 2026; holds 109,527 after (Direct).
  • Option exercise/conversion: disposed of 45,026 Stock Option (Right to Buy) on August 20, 2026 (Indirect).
  • Option exercise/conversion: disposed of 21,685 Stock Option (Right to Buy) on August 20, 2026; holds 115,853 after (Indirect).
  • Grant/award: acquired 200,000 Stock Option (Right to Buy) on August 20, 2026; holds 200,000 after (Direct).
  • Option exercise/conversion: disposed of 20,553 Stock Option (Right to Buy) on August 21, 2026; holds 88,974 after (Direct).
  • Option exercise/conversion: disposed of 21,055 Stock Option (Right to Buy) on August 21, 2026; holds 94,798 after (Indirect).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $269,967 of stock on the open market.

Insider Transactions

Daljit Singh Aurora — Officer (See Remarks)

DateTransactionSecuritySharesPriceValueHeld After
2026-08-20Option exercise/conversionCommon Stock67,741$1$48.8K116,491
2026-08-20Open-market saleCommon Stock67,741$2$102.6K48,750
2026-08-20Option exercise/conversionCommon Stock21,685$1$15.6K21,685
2026-08-20Option exercise/conversionCommon Stock45,026$1$32.4K66,711
2026-08-20Open-market saleCommon Stock66,711$2$101.0K0
2026-08-21Option exercise/conversionCommon Stock20,553$1$14.8K69,303
2026-08-21Open-market saleCommon Stock20,553$2$32.8K48,750
2026-08-21Option exercise/conversionCommon Stock21,055$1$15.2K21,055
2026-08-21Open-market saleCommon Stock21,055$2$33.6K0
2026-08-20Option exercise/conversionStock Option (Right to Buy)67,741——109,527
2026-08-20Option exercise/conversionStock Option (Right to Buy)45,026——0
2026-08-20Option exercise/conversionStock Option (Right to Buy)21,685——115,853
2026-08-20Grant/awardStock Option (Right to Buy)200,000——200,000
2026-08-21Option exercise/conversionStock Option (Right to Buy)20,553——88,974
2026-08-21Option exercise/conversionStock Option (Right to Buy)21,055——94,798

Key Dates

DateDescription
2026-08-20Option exercise/conversion (67,741 shares)
2026-08-20Open-market sale (67,741 shares)
2026-08-20Option exercise/conversion (21,685 shares)
2026-08-20Option exercise/conversion (45,026 shares)
2026-08-20Open-market sale (66,711 shares)
2026-08-21Option exercise/conversion (20,553 shares)
2026-08-21Open-market sale (20,553 shares)
2026-08-21Option exercise/conversion (21,055 shares)
2026-08-21Open-market sale (21,055 shares)
2026-08-20Option exercise/conversion (67,741 shares)
2026-08-20Option exercise/conversion (45,026 shares)
2026-08-20Option exercise/conversion (21,685 shares)
2026-08-20Grant/award (200,000 shares)
2026-08-21Option exercise/conversion (20,553 shares)
2026-08-21Option exercise/conversion (21,055 shares)

Keywords

insider transaction, Form 4, NMRA, Neumora Therapeutics, Inc., bearish, Daljit Singh Aurora

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.